Found: 2161
Select item for more details and to access through your institution.
Phase III XELOX Trial in Metastatic Colorectal Cancer Meets Primary Endpoints.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 14, p. 1871
- Publication type:
- Article
Unilateral distribution of cutaneous metastasis in a case of colon carcinoma.
- Published in:
- 2019
- By:
- Publication type:
- Case Study
Dose-Escalation and Pharmacokinetic Study Following a Single Dose of Oxaliplatin in Cancer-Bearing Dogs.
- Published in:
- Journal of the American Animal Hospital Association, 2020, v. 56, n. 4, p. 206, doi. 10.5326/JAAHA-MS-7007
- By:
- Publication type:
- Article
Treatment.
- Published in:
- 2008
- Publication type:
- Abstract
Foreword.
- Published in:
- Current Medical Literature: Colorectal Cancer, 2008, v. 2, n. 2, p. IV
- By:
- Publication type:
- Article
Treatment.
- Published in:
- Current Medical Literature: Colorectal Cancer, 2008, v. 2, n. 1, p. 21
- Publication type:
- Article
Neurotoxicity from oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: NSABP C-07.
- Published in:
- Current Medical Literature: Colorectal Cancer, 2007, v. 1, n. 3, p. 89
- Publication type:
- Article
Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (F0LF0X4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200.
- Published in:
- Current Medical Literature: Colorectal Cancer, 2007, v. 1, n. 3, p. 86
- Publication type:
- Article
Treatment - Adjuvant & Neoadjuvant Therapy.
- Published in:
- Current Medical Literature: Colorectal Cancer, 2007, v. 1, n. 2, p. 54
- Publication type:
- Article
Treatment - Adjuvant & Neoadjuvant Therapy.
- Published in:
- Current Medical Literature: Colorectal Cancer, 2007, v. 1, n. 1, p. 20
- Publication type:
- Article
Oxaliplatin preformulation studies for the development of innovative topical drug delivery systems.
- Published in:
- Journal of Thermal Analysis & Calorimetry, 2017, v. 130, n. 3, p. 1671, doi. 10.1007/s10973-017-6413-2
- By:
- Publication type:
- Article
Biocompatible tumor micro-environment responsive CS-g-PNIPAAm co-polymeric nanoparticles for targeted Oxaliplatin delivery.
- Published in:
- Journal of Polymer Research, 2018, v. 25, n. 3, p. 0, doi. 10.1007/s10965-018-1453-2
- By:
- Publication type:
- Article
OXA-CuS@UiO-66-NH<sub>2</sub> as a drug delivery system for Oxaliplatin to colorectal cancer cells.
- Published in:
- Journal of Materials Science: Materials in Medicine, 2022, v. 33, n. 3, p. 1, doi. 10.1007/s10856-021-06574-y
- By:
- Publication type:
- Article
Cytotoxicity and cellular response mechanisms of water-soluble platinum(II) complexes of lidocaine and phenylcyanamide derivatives.
- Published in:
- BioMetals, 2017, v. 30, n. 1, p. 59, doi. 10.1007/s10534-016-9986-5
- By:
- Publication type:
- Article
In vitro exosomal transfer of Nrf2 led to the oxaliplatin resistance in human colorectal cancer LS174T cells.
- Published in:
- Cell Biochemistry & Function, 2022, v. 40, n. 4, p. 391, doi. 10.1002/cbf.3703
- By:
- Publication type:
- Article
Increased understanding of platinum anticancer chemistry.
- Published in:
- Pure & Applied Chemistry, 2011, v. 83, n. 9, p. 1709, doi. 10.1351/PAC-CON-10-11-03
- By:
- Publication type:
- Article
Sequential therapy of refractory metastatic pancreatic cancer with 5-FU/LV/irinotecan (FOLFIRI) vs. 5-FU/LV/oxaliplatin (OFF). The PANTHEON trial (AIO PAK 0116).
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2024, v. 150, n. 7, p. 1, doi. 10.1007/s00432-024-05827-x
- By:
- Publication type:
- Article
Prognostic value of blood lipids on patients treated with oxaliplatin combined with S-1 (SOX) after radical gastrectomy and establishment of prognostic nomogram.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 12, p. 10293, doi. 10.1007/s00432-023-04942-5
- By:
- Publication type:
- Article
N<sup>6</sup>-methyladenosine (m<sup>6</sup>A) writer KIAA1429 accelerates gastric cancer oxaliplatin chemoresistance by targeting FOXM1.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 8, p. 5037, doi. 10.1007/s00432-022-04426-y
- By:
- Publication type:
- Article
Neoadjuvant PD-1 inhibitor and apatinib combined with S-1 plus oxaliplatin for locally advanced gastric cancer patients: a multicentered, prospective, cohort study.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 7, p. 4091, doi. 10.1007/s00432-022-04302-9
- By:
- Publication type:
- Article
Efficacy and tolerability of fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) in unselected patients with advanced gastric and gastroesophageal cancer: does age really matter?
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 5, p. 1849, doi. 10.1007/s00432-022-04109-8
- By:
- Publication type:
- Article
Hepatic arterial chemotherapy with raltitrexed and oxaliplatin versus standard chemotherapy in unresectable liver metastases from colorectal cancer after conventional chemotherapy failure (HEARTO): a randomized phase-II study.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2019, v. 145, n. 9, p. 2357, doi. 10.1007/s00432-019-02970-8
- By:
- Publication type:
- Article
Rechallenge with oxaliplatin and peripheral neuropathy in colorectal cancer patients.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2018, v. 144, n. 9, p. 1793, doi. 10.1007/s00432-018-2691-8
- By:
- Publication type:
- Article
Acinar cell carcinoma of the pancreas: a rare disease with different diagnostic and therapeutic implications than ductal adenocarcinoma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2016, v. 142, n. 12, p. 2585, doi. 10.1007/s00432-016-2264-7
- By:
- Publication type:
- Article
Value of FGFR2 expression for advanced gastric cancer patients receiving pazopanib plus CapeOX (capecitabine and oxaliplatin).
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2016, v. 142, n. 6, p. 1231, doi. 10.1007/s00432-016-2143-2
- By:
- Publication type:
- Article
Epirubicin combined with oxaliplatin and 5-day continuous infusion of 5-fluorouracil as a first-line treatment for metastatic gastric cancer: treatment outcomes and analysis of prognostic factors.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2015, v. 141, n. 1, p. 109, doi. 10.1007/s00432-014-1754-8
- By:
- Publication type:
- Article
Rituximab, Ara-C, dexamethasone and oxaliplatin (R-ADOx) is effective for treatment of elderly patients with relapsed mantle cell lymphoma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2013, v. 139, n. 10, p. 1771, doi. 10.1007/s00432-013-1475-4
- By:
- Publication type:
- Article
Validation study of a prognostic classification in patients with metastatic colorectal cancer who received irinotecan-based second-line chemotherapy.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2013, v. 139, n. 4, p. 595, doi. 10.1007/s00432-012-1349-1
- By:
- Publication type:
- Article
A tumor hypoxic niche protects human colon cancer stem cells from chemotherapy.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2013, v. 139, n. 2, p. 211, doi. 10.1007/s00432-012-1310-3
- By:
- Publication type:
- Article
Radioembolization and systemic chemotherapy improves response and survival for unresectable colorectal liver metastases.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2011, v. 137, n. 5, p. 865, doi. 10.1007/s00432-010-0948-y
- By:
- Publication type:
- Article
MGMT −535G>T polymorphism is associated with prognosis for patients with metastatic colorectal cancer treated with oxaliplatin-based chemotherapy.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2010, v. 136, n. 8, p. 1135, doi. 10.1007/s00432-010-0760-8
- By:
- Publication type:
- Article
Phase II study of capecitabine plus oxaliplatin (XELOX) as first-line treatment and followed by maintenance of capecitabine in patients with metastatic colorectal cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2010, v. 136, n. 4, p. 503, doi. 10.1007/s00432-009-0682-5
- By:
- Publication type:
- Article
Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer.
- Published in:
- European Radiology, 2012, v. 22, n. 9, p. 2035, doi. 10.1007/s00330-012-2459-5
- By:
- Publication type:
- Article
Interventional management of gastroduodenal lesions complicating intra-arterial hepatic chemotherapy.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Oxaliplatin/5fluorouracil-based chemotherapy was active and well tolerated in heavily pretreated patients with ovarian carcinoma.
- Published in:
- Archives of Gynecology & Obstetrics, 2008, v. 278, n. 5, p. 457, doi. 10.1007/s00404-008-0592-9
- By:
- Publication type:
- Article
Cryptogenic Organizing Pneumonia During Adjuvant Chemotherapy With Oxaliplatin, 5-Fluorouracil, and Leucovorin (FOLFOX) for Colon Cancer.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Organizing Pneumonia Associated with Oxaliplatin-Combined Chemotherapy: A Case Report.
- Published in:
- Medical Principles & Practice, 2011, v. 21, n. 1, p. 89, doi. 10.1159/000331898
- By:
- Publication type:
- Article
Oxaliplatin/5-Fluorouracil/Leucovorin (FOLFOX4) Regimen as an Adjuvant Chemotherapy in the Treatment of Advanced Jejunal Adenocarcinoma: A Report of 2 Cases.
- Published in:
- Medical Principles & Practice, 2008, v. 17, n. 6, p. 496, doi. 10.1159/000151574
- By:
- Publication type:
- Article
miR-122 Targets X-Linked Inhibitor of Apoptosis Protein to Sensitize Oxaliplatin-Resistant Colorectal Cancer Cells to Oxaliplatin-Mediated Cytotoxicity.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2018, v. 51, n. 5, p. 2148, doi. 10.1159/000495832
- By:
- Publication type:
- Article
Knockdown of Mir-135b Sensitizes Colorectal Cancer Cells to Oxaliplatin-Induced Apoptosis Through Increase of FOXO1.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2018, v. 48, n. 4, p. 1628, doi. 10.1159/000492284
- By:
- Publication type:
- Article
Astragaloside IV Induced miR-134 Expression Reduces EMT and Increases Chemotherapeutic Sensitivity by Suppressing CREB1 Signaling in Colorectal Cancer Cell Line SW-480.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2017, v. 43, n. 4, p. 1617, doi. 10.1159/000482025
- By:
- Publication type:
- Article
Bifidobacterium Infantis Ameliorates Chemotherapy-Induced Intestinal Mucositis Via Regulating T Cell Immunity in Colorectal Cancer Rats.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2017, v. 42, n. 6, p. 2330, doi. 10.1159/000480005
- By:
- Publication type:
- Article
Prognostic Significance of the Gustave-Roussy Immune Score in Colon Cancer Patients Treated with Adjuvant CAPEOX Regimen.
- Published in:
- Eurasian Journal of Medical Investigation, 2023, v. 7, n. 4, p. 433, doi. 10.14744/ejmi.2023.93298
- By:
- Publication type:
- Article
Effect of Adjuvant Chemotherapy/Chemoradiotherapy on Disease-Free Survival in Gastric Cancer.
- Published in:
- Eurasian Journal of Medical Investigation, 2022, v. 6, n. 4, p. 497, doi. 10.14744/ejmi.2022.22190
- By:
- Publication type:
- Article
The Clinical Effect of Triglyceride Glucose index, aninsulin Resistance Marker, on Predicting Paclitaxel-induced Neuropathy.
- Published in:
- Eurasian Journal of Medical Investigation, 2022, v. 6, n. 2, p. 180, doi. 10.14744/ejmi.2022.45197
- By:
- Publication type:
- Article
6-Shogaol enhances the anticancer effect of 5-fluorouracil, oxaliplatin, and irinotecan via increase of apoptosis and autophagy in colon cancer cells in hypoxic/aglycemic conditions.
- Published in:
- BMC Complementary Medicine & Therapies, 2020, v. 20, n. 1, p. 1, doi. 10.1186/s12906-020-02913-8
- By:
- Publication type:
- Article
Panitumumab.
- Published in:
- 2006
- By:
- Publication type:
- journal article
PEG-liposomal oxaliplatin induces apoptosis in human colorectal cancer cells via Fas/FasL and caspase-8.
- Published in:
- Cell Biology International, 2012, v. 36, n. 3, p. 289, doi. 10.1042/CBI20100825
- By:
- Publication type:
- Article
Ototoxicity among cisplatin, carboplatin, and oxaliplatin in zebrafish model.
- Published in:
- Environmental Toxicology, 2024, v. 39, n. 7, p. 4058, doi. 10.1002/tox.24285
- By:
- Publication type:
- Article
Silencing of IGHG1 reverses the resistance of pancreatic cancer to multidrug chemotherapy by modulating autophagy.
- Published in:
- Environmental Toxicology, 2023, v. 38, n. 8, p. 1835, doi. 10.1002/tox.23810
- By:
- Publication type:
- Article